Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. SPCX
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress

Verastem (VSTM) Misses Q2 EPS by 7c

August 1, 2019 5:26 PM EDT

Verastem (NASDAQ: VSTM) reported Q2 EPS of ($0.57), $0.07 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $3.14 million versus the consensus estimate of $2.32 million.

For earnings history and earnings-related data on Verastem (VSTM) click here.

... More